Shijiazhuang Yiling Pharmaceutical Co Ltd
002603.SZ · Health Technology · Pharmaceuticals: Major · CN
15,074 employees · yiling.cn
About
Shijiazhuang Yiling Pharmaceutical Co Ltd operates in the Health Care sector, specializing in pharmaceutical manufacturing. Headquartered in Shijiazhuang, Hebei, the company employs 15,074 people and produces cardiovascular and cerebrovascular drugs, anti-cold medications, and food and beverage products. It distributes its offerings domestically and internationally, having listed on the stock market in 2011.
Annual results
Reported figures, CNY · revenue up 20.2% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 7.8B | 1.3B | 16.4% | — |
| 2024 | 6.5B | -724M | -11.1% | — |
| 2023 | 10.3B | 1.4B | 13.1% | — |
| 2022 | 12.5B | 2.4B | 18.8% | — |
| 2021 | 10.1B | 1.3B | 13.3% | — |
Dividends per share
002603.SZ in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Shijiazhuang Yiling Pharmaceutical Co Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.